AEMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Aethlon Medical Inc (AEMD) is not a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock lacks positive catalysts, has weak financial performance, and no significant trading trends or analyst support. Additionally, technical indicators and proprietary trading signals do not suggest a strong entry point.
The MACD is slightly positive, indicating mild bullish momentum, but the RSI at 35.887 is neutral and does not provide a clear signal. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels, suggesting a weak technical setup.
NULL identified. There are no recent news, trading trends, or significant events to act as positive catalysts.
and a YoY decline of -75.62%. Additionally, there is no recent insider or hedge fund activity, no congress trading data, and no analyst ratings or price target changes available.
In Q3 2026, revenue remained at 0 with no growth. Net income improved slightly but remains negative at -2,018,245, up 15.01% YoY. EPS dropped significantly by -75.62% YoY to -2.45, indicating poor profitability. Gross margin remains at 0.
No data available for analyst ratings or price target changes.
